The pathophysiology of faecal spotting in obese subjects during treatment with orlistat

Alimentary Pharmacology and Therapeutics

Volumn 19, Issue 3, 2004, Pages 311-321

  Fox, M ^a   Thumshirn, M ^a   Menne, D ^b   Stutz, B ^a   Fried, M ^a   Schwizer, W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Menne Biomed   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FECES LIPID; PLACEBO; TETRAHYDROLIPSTATIN; WATER;

ADULT; ANORECTAL PRESSURE; ANUS CONTINENCE; ANUS SPHINCTER; ARTICLE; BAROSTAT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FECES; FECES INCONTINENCE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MALE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RECTUM; SENSATION;

ADULT; ANTI-OBESITY AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FECAL INCONTINENCE; FECES; FEMALE; HUMANS; LACTONES; MALE; MANOMETRY; MEDICAL RECORDS; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 1342289026     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01848.x     Document Type: Article

References (23)

1. Sjostrom L, Rissanen A, Andersen T, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998; 352: 167-72.
2. Rossner S, Sjostrom L, Noack R, Meinders AE, Noseda G. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res 2000; 8: 49-61.
3. Zhi J, Melia AT, Guerciolini R, et al. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol Ther 1994; 56: 82-5.
4. Heymsfield SB, Segal KR, Hauptman J, et al. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 2000; 160: 1321-6.
5. Read NW, Harford WV, Schmulen AC, Read MG, Santa Ana C, Fordtran JS. A clinical study of patients with fecal incontinence and diarrhea. Gastroenterology 1979; 76: 747-56.
6. Read MG, Read NW. Role of anorectal sensation in preserving continence. Gut 1982; 23: 345-7.
7. Siproudhis L, Bellissant E, Juguet F, Allain H, Bretagne JF, Gosselin M. Perception of and adaptation to rectal isobaric distension in patients with faecal incontinence. Gut 1999; 44: 687-92.
8. Rao SS, Read NW, Davison PA, Bannister JJ, Holdsworth CD. Anorectal sensitivity and responses to rectal distention in patients with ulcerative colitis. Gastroenterology 1987; 93: 1270-5.
9. Salvioli B, Bharucha AE, Rath-Harvey D, Pemberton JH, Phillips SF. Rectal compliance, capacity, and rectoanal sensation in fecal incontinence. Am J Gastroenterol 2001; 96: 2158-68.
10. Sun WM, Donnelly TC, Read NW. Utility of a combined test of anorectal manometry, electromyography, and sensation in determining the mechanism of 'idiopathic' faecal incontinence. Gut 1992; 33: 807-13.
11. Wald A, Tunuguntla AK. Anorectal sensorimotor dysfunction in fecal incontinence and diabetes mellitus. Modification with biofeedback therapy. N Engl J Med 1984; 310: 1282-7.
12. Read NW, Bartolo DC, Read MG. Differences in anal function in patients with incontinence to solids and in patients with incontinence to liquids. Br J Surg 1984; 71: 39-42.
13. Fox M, Schwizer W, Menne D, Fried M, Thumshirn M. The measurement of rectal capacity by barostat techniques. Gut 2003; 52(Suppl. VI): A91(Abstract).
14. Fox M, Thumshirn M, Menne D, Fried M, Schwizer W. The determinants of anorectal sensation and continence in health. Swiss Med Forum 2003; 3(Suppl. 14): S22(Abstract).
15. Felt-Bersma RJ, Klinkenberg-Knol EC, Meuwissen SG. Anorectal function investigations in incontinent and continent patients. Differences and discriminatory value. Dis Colon Rectum 1990; 33: 479-85; discussion 485-76.
16. Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. Dig Dis Sci 1997; 42: 223-41.
17. Diamant NE, Kamm MA, Wald A, Whitehead WE. AGA technical review on anorectal testing techniques. Gastroenterology 1999; 116: 735-60.
18. Miller R, Bartolo DC, Roe A, Cervero F, Mortensen NJ. Anal sensation and the continence mechanism. Dis Colon Rectum 1988; 31: 433-8.
19. Andriesse GI, Gooszen HG, Schipper ME, Akkermans LM, van Vroonhoven TJ, van Laarhoven CJ. Functional results and visceral perception after ileo neo-rectal anastomosis in patients: a pilot study. Gut 2001; 48: 683-9.
20. Engel AF, Kamm MA, Bartram CI, Nicholls RJ. Relationship of symptoms in faecal incontinence to specific sphincter abnormalities. Int J Colorectal Dis 1995; 10: 152-5.
21. Sun WM, Read NW, Miner PB. Relation between rectal sensation and anal function in normal subjects and patients with faecal incontinence. Gut 1990; 31: 1056-61.
22. Rasmussen O, Christensen B, Sorensen M, Tetzschner T, Christiansen J. Rectal compliance in the assessment of patients with fecal incontinence. Dis Colon Rectum 1990; 33: 650-3.
23. Diamant NE, Harris LD. Comparison of objective measurement of anal sphincter strength with anal sphincter pressures and levator ani function. Gastroenterology 1969; 56: 110-6.